Who owns the QEYOMY trademark?

The QEYOMY trademark is owned by QED Therapeutics, Inc..

What is the serial number for QEYOMY?

The USPTO serial number for QEYOMY is 90262916.

What is the registration number for QEYOMY?

QEYOMY is registered under USPTO registration number 0.

QEY

USPTO Trademark Record

ABANDONED

QEYOMY

Q: What class is the QEYOMY trademark registered in?

The QEYOMY trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 90262916·Reg 0·Filed Oct 19, 2020

Owner QED Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

QEYOMY (Serial No. 90262916), Registration No. 0, is a abandoned US trademark filed on Oct 19, 2020 by QED Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

QEYOMY (Reg. #0) is an abandoned US trademark that was filed in 2020 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 19, 2020

SERIAL

90262916

REG#

Owner

Applicant

QED Therapeutics, Inc.

Entity

Corporation

State

Address

800 Marina Blvd., Brisbane, CA, 94005

Country

Attorney

NameJessica L. Rothstein

Law firm

JESSICA L. ROTHSTEIN GOODWIN PROCTER LLP

Docket

138331273401

Address

620 EIGHTH AVENUE, 620 EIGHTH AVENUE, NEW YORK, NY 10018, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateOct 19, 2020

Serial Number90262916

Registration No.0

Status DateApr 22, 2024

Published for OppositionJul 25, 2023

Mark TypeStandard characters

Attorney Docket138331273401

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

16 events

ABANDONMENT - NO USE STATEMENT FILED

Apr 22, 2024

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Apr 22, 2024

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 19, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 25, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 25, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 05, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 19, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Dec 15, 2022

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

May 13, 2022

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Sep 20, 2021

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

SUSPENSION LETTER WRITTEN

Mar 20, 2021

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Mar 20, 2021

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Mar 20, 2021

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

ASSIGNED TO EXAMINER

Mar 18, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 06, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 22, 2020

NEW APPLICATION ENTERED

QEYOMY

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by QED Therapeutics, Inc.

Other Marks by Jessica L. Rothstein

Resources

Company